BMY : NYSE
Industry: Pharmaceuticals

Balance Sheet
2008
12/31/08
2007
12/31/07
2006
12/31/06
2005
12/31/05
Cash7,9761,8012,0183,050
Short Term Investments2894241,9952,749
ASSETS
Cash & Short Term Investments8,2652,2254,0135,799
Receivables - Net3,7104,2403,2473,378
Raw Materials320424394514
Work in Progress738834682679
Finished Goods7079041,003867
Inventories - Total1,7652,1622,0792,060
Prepaid Expenses320310314270
Other Current Assets7031,411649776
CURRENT ASSETS - TOTAL14,76310,34810,30212,283
Land149185254280
Buildings4,5064,6964,6304,560
Machinery & Equipment4,0074,4184,5404,574
Property, Plant and Equipment - Gross9,44910,21410,1449,984
Accumulated Depreciation(4,044)(4,564)(4,471)(4,291)
Property, Plant and Equipment - Net5,4055,6505,6735,693
Deferred Charges------1,324
Other Tangible Assets1,2691,130342286
Total Intangible Other Assets - Net5,9786,3286,6816,744
Other Assets - Total9,38410,1749,6008,354
TOTAL ASSETS27,41523,45622,99826,330
LIABILITIES
Accounts Payable1,5351,4421,2391,579
Short Term Debt & Current Portion of Long Term Debt1541,891187231
Accrued Payroll874------
Income Taxes Payable347296444538
Dividends Payable617614552547
Other Current Liabilities3,1834,4014,0743,995
CURRENT LIABILITIES - TOTAL6,7108,6446,4966,890
Long Term Debt6,5854,3817,2488,364
Provision for Risks and Charges2,285782942804
Deferred Income791714354241
Deferred Taxes - Debit2,1372,7162,577--
DEFERRED TAXES(2,137)(2,716)(2,577)(1,808)
Other Liabilities9401,089544631
TOTAL LIABILITIES15,17412,89413,00715,122
EQUITY
Non-Equity Reserves0000
Minority Interest0000
Preferred Stock--------
Common Stock220220220220
Capital Surplus2,8282,7222,6262,528
Other Appropriated Reserves(2,329)(1,070)(1,339)(300)
Retained Earnings22,54919,76219,84520,464
Unrealized Foreign Exchange Gain/Loss(410)(362)(447)(537)
Unrealized Gain/Loss on Marketable Securities(51)(126)131
Treasury Stock(10,566)(10,584)(10,927)(11,168)
COMMON EQUITY12,24110,5629,99111,208
TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY27,41523,45622,99826,330
SHARE INFORMATION
Common Shares Outstanding1,9741,9741,9621,957
2009 Q3
9/30/09
2009 Q2
6/30/09
2009 Q1
3/31/09
2008 Q4
12/31/08
2008 Q3
9/30/08
Cash------7,976--
ASSETS
Cash & Short Term Investments6,6698,1208,9208,2657,431
Receivables - Net3,6993,6193,6003,7104,224
Inventories - Total1,8241,7801,7351,7652,055
Prepaid Expenses493385361320378
Other Current Assets702666759703691
CURRENT ASSETS - TOTAL13,38714,57015,37514,76314,779
Property, Plant and Equipment - Gross9,9049,6749,4689,4499,578
Accumulated Depreciation(4,343)(4,206)(4,082)(4,044)(4,218)
Property, Plant and Equipment - Net5,5615,4685,3865,4055,360
Investments in Associated Companies1,202983--0--
Total Intangible Other Assets - Net8,2015,8975,9345,9786,053
Other Assets - Total10,8018,7888,9329,3848,337
TOTAL ASSETS29,51428,00727,74927,41527,357
LIABILITIES
Accounts Payable1,7961,8021,6951,5351,441
Short Term Debt & Current Portion of Long Term Debt286124156154135
Income Taxes Payable433394446347199
Other Current Liabilities4,8774,4244,3364,6745,176
CURRENT LIABILITIES - TOTAL7,3926,7446,6336,7106,951
Long Term Debt5,0265,0156,4926,5856,120
Deferred Taxes - Debit1,4371,8021,9442,1371,119
DEFERRED TAXES(1,437)(1,802)(1,944)(2,137)(1,119)
Other Liabilities4,1624,1143,4394,0162,467
TOTAL LIABILITIES15,14314,07114,62015,17414,419
EQUITY
Non-Equity Reserves------00
Minority Interest(147)160(208)00
Preferred Stock00------
Common Stock220220220220220
Capital Surplus3,8083,7903,7592,8282,800
Retained Earnings23,28722,93622,57122,54921,919
Unrealized Foreign Exchange Gain/Loss(426)(430)(438)(410)(349)
Unrealized Gain/Loss on Marketable Securities(16)(37)(49)(51)(101)
Treasury Stock(10,504)(10,508)(10,510)(10,566)(10,571)
COMMON EQUITY14,51813,77613,33712,24112,938
TOTAL LIABILITIES & SHAREHOLDERS’ EQUITY29,51428,00727,74927,41527,357
SHARE INFORMATION
Common Shares Outstanding1,9761,9761,9761,9741,974
() = Negative Values
Values are displayed in Millions except for earnings per share and where noted